These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26049677)

  • 21. Expression Analysis of Protein Inhibitor of Activated STAT in Inflammatory Demyelinating Polyradiculoneuropathy.
    Ghafouri-Fard S; Hussen BM; Nicknafs F; Nazer N; Sayad A; Taheri M
    Front Immunol; 2021; 12():659038. PubMed ID: 34054823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory nerve conduction in demyelinating and axonal Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Misawa S; Mizobuchi K; Sung JY; Kitano Y; Mori M; Hattori T
    Eur Neurol; 2004; 51(4):196-8. PubMed ID: 15159599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Narasimhan M
    Clin Neurophysiol; 2007 Sep; 118(9):1999-2004. PubMed ID: 17644033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
    Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.
    Ruts L; van Koningsveld R; van Doorn PA
    Neurology; 2005 Jul; 65(1):138-40. PubMed ID: 16009902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression analysis of BDNF, BACE1 and their antisense transcripts in inflammatory demyelinating polyradiculoneuropathy.
    Ghafouri-Fard S; Mazdeh M; Nicknafs F; Nazer N; Sayad A; Taheri M
    Mult Scler Relat Disord; 2021 Jan; 47():102613. PubMed ID: 33160139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iMAX: A new tool for assessment of motor axon excitability. A multicenter prospective study.
    Tyberghein M; Grapperon AM; Bouquiaux O; Puma A; Attarian S; Wang FC
    Clin Neurophysiol; 2022 Jan; 133():20-28. PubMed ID: 34800836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New criteria for early electrodiagnosis of acute inflammatory demyelinating polyneuropathy.
    Al-Shekhlee A; Hachwi RN; Preston DC; Katirji B
    Muscle Nerve; 2005 Jul; 32(1):66-72. PubMed ID: 15880488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guillain-Barre or CIDP? That is the question.
    Smith BE
    Neurology; 2010 May; 74(21):1664-5. PubMed ID: 20445150
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic value of myotactic reflexes in axonal and demyelinating polyneuropathy.
    van Dijk GW; Wokke JH; Notermans NC; van Gijn J; Franssen H
    Neurology; 1999 Oct; 53(7):1573-6. PubMed ID: 10534270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor unit number index (MUNIX): principle, method, and findings in healthy subjects and in patients with motor neuron disease.
    Nandedkar SD; Barkhaus PE; Stålberg EV
    Muscle Nerve; 2010 Nov; 42(5):798-807. PubMed ID: 20976783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
    Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
    Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy.
    Comi C; Gaviani P; Leone M; Ferretti M; Castelli L; Mesturini R; Ubezio G; Chiocchetti A; Osio M; Muscia F; Bogliun G; Corso G; Gavazzi A; Mariani C; Cantello R; Monaco F; Dianzani U
    J Peripher Nerv Syst; 2006 Mar; 11(1):53-60. PubMed ID: 16519782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy.
    Oh SJ; LaGanke C; Powers R; Wolfe GI; Quinton RA; Burns DK
    Neurology; 2005 Nov; 65(10):1639-42. PubMed ID: 16301495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Levels of Il-19 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy.
    Sangsefidi S; Ghafouri-Fard S; Komaki A; Mazdeh M; Taheri M; Eftekharian MM
    J Mol Neurosci; 2020 Dec; 70(12):1997-2000. PubMed ID: 32472395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Diagnostic Panel for Acquired Immune-Mediated Polyneuropathies Based on the Expression of lncRNAs.
    Hussen BM; Nicknafs F; Hidayat HJ; Sayad A; Ghafouri-Fard S; Taheri M
    Front Immunol; 2021; 12():643615. PubMed ID: 33708228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes.
    Kuwabara S; Ogawara K; Sung JY; Mori M; Kanai K; Hattori T; Yuki N; Lin CS; Burke D; Bostock H
    Ann Neurol; 2002 Aug; 52(2):180-7. PubMed ID: 12210788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restless legs syndrome in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Shah RS
    Muscle Nerve; 2010 Aug; 42(2):252-6. PubMed ID: 20544936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.